512.65 USD
↘ 1.14 (0.22%)AT CLOSE (11:59 AM EDT)
Madrigal Pharmaceuticals, Inc. Common Stock
MDGLNASDAQ • USD
508.75
↘ 3.90 (0.76%)
POST MARKET (AS OF 04:53 PM EDT)
Post Market
AS OF 04:53 PM EDT
508.75
↘ 3.90 (0.76%)
Market: CLOSED
Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) is currently trading at $512.65. The technical outlook is "Strong Buy" and the fundamental picture shows "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Jun 26, 2026.
Open?$517.66
High?$532.33
Low?$505.63
Prev. Close?$513.79
Volume?2.5M
Avg. Volume?362.0K
VWAP?$519.61
Rel. Volume?6.91x
Bid / Ask
Bid?$505.50 × 120
Ask?$526.00 × 40
Spread?$20.50
Midpoint?$515.75
Valuation & Ratios
Market Cap?11.8B
Shares Out?23.1M
Float?16.5M
Float %?71.7%
P/E Ratio?N/A
P/B Ratio?21.75
EPS?-$13.42
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
Employees
915
Market Cap
11.8B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2007-02-06
Address
200 BARR HARBOR DRIVE, SUITE 400
WEST CONSHOHOCKEN, PA 19428
Phone: 404-380-9263
WEST CONSHOHOCKEN, PA 19428
Phone: 404-380-9263
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?100
Momentum?73
Short Sent.?39
Piotroski F-Score?1/9Weak
Altman Z-Score?8.78Safe
Confidence?58%Low
Short InterestSqueeze Risk
Short % of Float?22.87%Squeeze Risk
Short Interest?3.8M
Days to Cover?14.3
Free Float16.5M
Avg Daily Volume264.0K
Settlement Date2026-06-15
Financial Health
Current Ratio?3.48Strong
Quick Ratio?3.15Strong
Cash Ratio?0.67Adequate
Debt/Equity?0.63Moderate
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score50/100
P/E?N/A▾
P/B?21.75HIGH▾
Peers100
S&P6
P/S?10.44HIGH▾
Peers100
S&P8
P/FCF?N/A▾
EV/EBITDA?-38.3CHEAP▾
S&P97
EV/Sales?10.54HIGH▾
Peers100
S&P10
Returns & Efficiency
ROE?-56.9%WEAK▾
S&P3
ROA?-25.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-272413000
Enterprise Value?$11.9B
Fundamentals ratios updated end of day